Fig. 2

Geometric means (with 95% CI) of circulating (a) irisin and (b) adiponectin according to the number of metabolic syndrome components at baseline. The number of participants in each group was as follows: 0 (n = 16), 1 (n = 71), 2 (n = 103), 3 (n = 85), and 4–5 components (n = 73).